Biopharma – Making products better together

In the rapidly evolving pharmaceutical and medical device industries, companies are constantly striving to bring safe, innovative, and more effective biopharma products to the market, while also seeking to reduce rising healthcare costs.


With over 25 years’ experience in the biopharmaceutical industry, Novozymes Biopharma is dedicated to providing biological-based ingredients and technologies, such as recombinant albumin, hyaluronic acid and enzymes for the pharmaceutical and medical device industries.
We help partners overcome challenges  throughout their development process, supporting them with everything from more sustainable biocatalytic processes for optimized manufacturing to improved drug stabilization and half-life extension for therapeutics formulations.

Novozymes recombinant albumin and hyaluronic acid are produced in large-scale manufacturing facilities around the world. These are operated to Q7 cGMP quality standards to ensure the highest level of product quality, consistency, and security of long-term supply.
We offer customized solutions and support throughout the development process, backing all our products and technologies  with a wealth of scientific, technical and regulatory knowledge that helps our partners move faster to market with improved treatments for patients.